General Motors tackles steep tariff challenges with targeted US plant shifts and a $4B investment playbook. Read my Q2 ...

GSK PLC closed 19.70% below its 52-week high of £16.79, which the company achieved on September 9th.

The Swedish defense company posted better-than-expected earnings and [raised its annual sales guidance]( ...

GSK shares fell after a Food and Drug Administration advisory committee voted against approval of the company's Blenrep drug, a setback for its bid to reintroduce the blood-cancer treatment in the U.S ...

Arexvy is currently approved for use in all individuals aged 60 and older, as well as for high-risk individuals aged 50-59.

AnaptysBio’s lead drug rosnilimab showed promise in RA, but lack of a Phase 3 plan and limited pipeline raise concerns. Find ...